Colgate-Palmolive Co. (CL)

NASDAQConsumer Defensive

$84.76
-$0.67 (-0.8%)
Last close

January 21, 2026 at 21:00 UTC

Interactive Chart
CL
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Colgate-Palmolive Co.

Name

Colgate-Palmolive Co.

CEO

Noel R. Wallace

Industry

Consumer Defensive

Year Founded

1806

Employees

34,000

Colgate-Palmolive Co. makes everyday consumer products with a focus on oral, personal and home care, and pet nutrition. The company builds brands that appear in supermarkets, pharmacies, and e-commerce channels, and it supports them with steady innovation, packaging updates, and education about hygiene and wellness. Manufacturing and sourcing run across the Americas, Europe, Asia, and Africa, with formulas adapted to local tastes and regulations. Distribution uses both retail partners and direct relationships to keep shelves stocked and digital orders fulfilled. The business sits in the consumer staples sector, where recurring demand and brand trust matter. Colgate-Palmolive Co. stock (CL) is often discussed in the context of global household and personal products, and the ticker connects the company to conversations about brand portfolios and category mix.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 13 Buy, 5 Hold, 3 Sell
Buy13
Hold5
Sell3
Fundamentals & Financials
Revenue (TTM)
$20B
Net Income (TTM)
$2.9B
EPS (TTM)
$3.59
ROA (TTM)
16.6%
Current Ratio
0.93
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue$5,131M
Cost of Sales$2,082M
Gross Profit$3,049M
Operating Income$1,097M
Net Income$735,000K
EPS$0.91
Technical Indicators

Colgate-Palmolive Co.'s Technical Indicators Summary

Crude oil (CL) maintains a bullish posture with strong momentum evident from a robust MACD level and a high CCI value, signaling buying interest despite the RSI nearing overbought territory. The price comfortably trades above its short- and medium-term moving averages, reinforcing the upward trend, though it hovers near the 200-day SMA, which suggests some resistance. Volatility remains moderate, as indicated by a stable ATR, while the ADX reflects a trend that is neither weakening nor gaining significant strength. Additionally, the positive On-Balance Volume supports the buying pressure. Overall, these factors combine to underline a solid but cautiously monitored upward trend.

Buy
13 signals
Neutral
5 signals
Sell
3 signals
Overall: Bullish62% Bullish signals
IndicatorValue
RSI (14)
69.70
Stochastic %K (14, 3, 3)
93.21
CCI (20)
159.56
WPR (14)
-6.24
Momentum (10)
6.83
MFI
72.44
MACD Level (12, 26)
1.36
Bollinger Bands
$75.19 - $85.09
ATR (14)
$1.47 (1.74%)
ADX (14)
22.13
OBV
-36,244,100
Simple Moving Averages
$79.24 - $84.67(5 indicators)
Exponential Moving Averages
$79.85 - $84.18(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

End-of-day trade saw CL unable to fully erase the -0.224% gap down from yesterday, settling near 84.73. End-of-session options data show a constructive lean in CL, with PCR at 0.65. Colgate's recent WHO partnership boosts its public health profile; stock remains undervalued amid positive momentum.

Price Change

from $84.92 close

$-0.19

Trading Volume

Below avg (8.1M)

5.5M

vs S&P 500 Today

Underperforming Market

-1.38%

52-Week Position

Mid-range

39.7%

Updated: January 21, 2026 at 21:06 UTC

Quote Summary
OpenPrevious Close
$84.69$84.92
Day Range52 Week Range
$83.82 - $85.13$74.55 - $100.18
VolumeAvg. Volume
3.3M6.7M
Market CapP/E Ratio
$68.1B23.7